SCHEMBL23795253

SCHEMBL23795253

CC1(c2ccccc2)CC(C)(c2ccc(Cl)cc2)c2ccccc21

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TP53 P04637 7/20 0.54
SMN1; SMN2 Q16637 5/20 0.54
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ADRB2 P07550 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
THRB P10828 1/20 0.44
MAPT P10636 3/20 0.43
CCR2 P41597 2/20 0.41
FSHR P23945 1/20 0.40
PLIN1 O60240 1/20 0.40
ALDH1A1 P00352 1/20 0.40
PLIN5 Q00G26 1/20 0.40
ABHD5 Q8WTS1 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
ATM Q13315 1/20 0.40
CNR1 P21554 1/20 0.39
USP2 O75604 1/20 0.39
SLC6A3 Q01959 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23795250 0.96 TP53 (0.52) TP53SMN1; SMN2MEN1KMT2AADRB2
SCHEMBL23795275 0.90 TP53 (0.49) TP53SMN1; SMN2MEN1KMT2AADRB2
SCHEMBL21925724 0.90 TP53 (0.49) TP53SMN1; SMN2MEN1KMT2AADRB2
SCHEMBL23795268 0.88 MEN1 (0.50) TP53SMN1; SMN2MEN1KMT2AADRB2
SCHEMBL23795303 0.79 TP53 (0.43) TP53SMN1; SMN2MEN1KMT2AADRB2
SCHEMBL24177590 0.78 SMN1; SMN2 (0.39) TP53SMN1; SMN2MEN1KMT2AADRB2
SCHEMBL503853 0.78 MEN1 (0.46) TP53SMN1; SMN2MEN1KMT2AADRB2
SCHEMBL29436894 0.78 MEN1 (0.46) TP53SMN1; SMN2MEN1KMT2AADRB2
SCHEMBL6899070 0.76 MEN1 (0.45) TP53SMN1; SMN2MEN1KMT2AADRB2
Water SCHEMBL27831248 0.76 MEN1 (0.45) TP53SMN1; SMN2MEN1KMT2AADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12127473-B2 Di-, tri- and tetraphenylindane derivates and their use in organic electronics DOTTIKON ES HOLDING AG (CH) 2024-10-22 US disclosed
US-20220006020-A1 DI-, TRI- AND TETRAPHENYLINDANE DERIVATES AND THEIR USE IN ORGANIC ELECTRONICS DOTTIKON ES HOLDING AG (CH) 2022-01-06 US disclosed
EP-3877357-A1 DI-, TRI- AND TETRAPHENYLINDANE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONICS DOTTIKON ES HOLDING AG (CH) 2021-09-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220006020-A1 DI-, TRI- AND TETRAPHENYLINDANE DERIVATES AND THEIR USE IN ORGANIC ELECTRONICS NR0B2, KCNJ2, TRRAP TP53 3228/4885SMN1; SMN2 3918/4885MEN1 2154/4885
US-12127473-B2 Di-, tri- and tetraphenylindane derivates and their use in organic electronics NR0B2, KCNJ2, TRRAP TP53 3228/4885SMN1; SMN2 3918/4885MEN1 2154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.